CRISM developed the first national injectable opioid agonist treatment (iOAT) guideline in the world. This guideline includes two companion documents: a clinical guideline and an operational guidance document.

A synopsis of the Guideline was published in the Canadian Medical Association Journal

A podcast was also produced by CMAJ, which can be found at the link above.

You can also access the Guideline Development Methodology (as supplied by the authors) here

Join our Community of Practice

If you work at an iOAT clinic or are seeking to learn more, email Karen McCrae at to subscribe to access our members only page and join our mailing list

Supplemental Materials